- Home
- ALLK vs HWH Comparison
ALLK vs HWH Comparison
Compare ALLK & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- HWH
- Stock Information
- Founded
- ALLK 2012
- HWH 2021
- Country
- ALLK United States
- HWH United States
- Employees
- ALLK N/A
- HWH N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- HWH Other Pharmaceuticals
- Sector
- ALLK Health Care
- HWH Health Care
- Exchange
- ALLK Nasdaq
- HWH Nasdaq
- Market Cap
- ALLK 23.0M
- HWH 21.2M
- IPO Year
- ALLK 2018
- HWH N/A
- Fundamental
- Price
- ALLK $0.32
- HWH $1.23
- Analyst Decision
- ALLK Hold
- HWH
- Analyst Count
- ALLK 3
- HWH 0
- Target Price
- ALLK $2.00
- HWH N/A
- AVG Volume (30 Days)
- ALLK 1.8M
- HWH 582.3K
- Earning Date
- ALLK 03-12-2025
- HWH 05-14-2025
- Dividend Yield
- ALLK N/A
- HWH N/A
- EPS Growth
- ALLK N/A
- HWH N/A
- EPS
- ALLK N/A
- HWH N/A
- Revenue
- ALLK N/A
- HWH $1,253,577.00
- Revenue This Year
- ALLK N/A
- HWH N/A
- Revenue Next Year
- ALLK N/A
- HWH N/A
- P/E Ratio
- ALLK N/A
- HWH N/A
- Revenue Growth
- ALLK N/A
- HWH 50.94
- 52 Week Low
- ALLK $0.22
- HWH $1.17
- 52 Week High
- ALLK $1.56
- HWH $15.75
- Technical
- Relative Strength Index (RSI)
- ALLK 59.90
- HWH 38.32
- Support Level
- ALLK $0.24
- HWH $1.18
- Resistance Level
- ALLK $0.27
- HWH $1.36
- Average True Range (ATR)
- ALLK 0.01
- HWH 0.17
- MACD
- ALLK 0.01
- HWH -0.02
- Stochastic Oscillator
- ALLK 96.94
- HWH 10.37
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.
About HWH HWH International Inc.
HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.